Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IMPI: Prednisolone and Mycobacterium w in Tuberculous Pericarditis
NCT00810849Phase 3Completed
- Sponsor
- University of Cape Town
- Start
- Dec 2008
- Primary completion
- Feb 2014
- Modality
- Prophylactic Vaccines, Microbiome Therapeutics, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of prednisolone, MYCIDAC-C in Tuberculous pericarditis (TP), sponsored by University of Cape Town. Started Dec 2008; status: completed.
02
Drugs
prednisoloneMYCIDAC-C
03
Conditions
Tuberculous pericarditis (TP)
Beyond the preview
Go deeper on NCT00810849.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00810849.